NEW YORK (GenomeWeb News) – Following Hologic's $3.7 billion agreement to acquire Gen-Probe, the molecular diagnostics space may be on the verge of some industry consolidation, according to investment analysts.

Yesterday, Hologic announced the $82.75 per-share offer for Gen-Probe, concluding a search Gen-Probe began a year ago for a buyer. The deal has some industry observers considering which other MDx firms may be ripe for a deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.